Arsen Osipov

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 21 papers. Top paper: “Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma”.

Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma

Scientific Reports(2022)10.1038/s41598-022-19401-3

N/A

0.587DataRank · unranked

10 citations

Shant Thomassian, Sungjin Kim, Gillian Gresham, Natalie Moshayedi, Jason Ye +9 more

Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic Adenocarcinoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2974

N/A

0DataRank · unranked

78 citations

Ding Ding, Barish H. Edil, Carol Judkins, Jennifer N. Durham, Dwayne L. Thomas +32 more

Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient‐reported outcomes in pancreatic cancer cachexia

Journal of Cachexia Sarcopenia and Muscle(2021)10.1002/jcsm.12799

N/A

0DataRank · unranked

24 citations

Veronica Placencio-Hickok, Marie Lauzon, Tyra Nguyen, Haesoo Kim, Sejal Mehta +9 more

Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy

Cancer Cell(2022)10.1016/j.ccell.2022.10.001

N/A

0DataRank · unranked

178 citations

Joseph A. Tandurella, Jessica Gai, Qingfeng Zhu, Su Jin Lim, Dwayne L. Thomas +26 more

Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses

Journal of Hematology & Oncology(2022)10.1186/s13045-022-01253-z

N/A

0DataRank · unranked

73 citations

Keyu Li, Nan Niu, Yingkuan Shao, Ding Ding, Dwayne L. Thomas +13 more

Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy

Gastroenterology(2022)10.1053/j.gastro.2022.06.027

N/A

0DataRank · unranked

76 citations

Jianxin Wang, John Davelaar, Andrew Baker, Keyu Li, Nan Niu +17 more

Trial in progress: A randomized phase II study of pembrolizumab with or without defactinib, a focal adhesion kinase inhibitor, following chemotherapy as a neoadjuvant and adjuvant treatment for resectable pancreatic ductal adenocarcinoma (PDAC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps4192

N/A

0DataRank · unranked

6 citations

Zachariah Brown, Sheila Linden, Christina Rodriguez, Omer H. Elmadbouh, Jonathan A. Pachter +9 more

Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma

Scientific Reports(2022)10.1038/s41598-022-23619-6

N/A

0DataRank · unranked

1 citations

Shant Thomassian, Sungjin Kim, Gillian Gresham, Natalie Moshayedi, Jason Ye +9 more

Recent advances in the management of hepatocellular carcinoma

Clinical and Molecular Hepatology(2023)10.3350/cmh.2023.0125

N/A

0DataRank · unranked

138 citations

Jun Gong, Arsen Osipov, Steven A. Miles, Kambiz Kosari, Nicholas N. Nissen +4 more

Role Of YAP Signaling in Regulation of Programmed Cell Death and Drug Resistance in Cancer

International Journal of Biological Sciences(2023)10.7150/ijbs.83586

N/A

0DataRank · unranked

39 citations

Adrian Lim, Mouad Edderkaoui, Arsen Osipov, Heshui Wu, Qiang Wang +2 more

COVID-19 Pandemic Impact on Diagnosis, Stage, and Treatment of Hepatocellular Carcinoma in the United States

Gastro Hep Advances(2023)10.1016/j.gastha.2023.11.011

N/A

0DataRank · unranked

6 citations

Yee Hui Yeo, Jeff Liang, Michael Luu, Walid S. Ayoub, Alexander Kuo +11 more

Preliminary translational immune and stromal correlates in a randomized phase II trial of pembrolizumab with or without defactinib for resectable pancreatic ductal adenocarcinoma (PDAC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4024

N/A

0DataRank · unranked

5 citations

John Davelaar, Jessica Gai, Zachariah Brown, Abrahm Levi, Sheila Linden +15 more

The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients

Nature Cancer(2024)10.1038/s43018-023-00697-7

N/A

0DataRank · unranked

87 citations

Ognjen Nikolic, Arkadiusz Gertych, Sarah J. Parker, Andrew Hendifar, Pranav Singh +9 more

Overcome the challenge for intratumoral injection of STING agonist for pancreatic cancer by systemic administration

Journal of Hematology & Oncology(2024)10.1186/s13045-024-01576-z

N/A

0DataRank · unranked

20 citations

Junke Wang, Rui Zhang, Jiawei Zhou, Birginia Espinoza, Nan Niu +18 more

Verteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells

Free Radical Biology and Medicine(2024)10.1016/j.freeradbiomed.2024.01.003

N/A

0DataRank · unranked

22 citations

Adrian Lim, Omer H. Elmadbouh, Mouad Edderkaoui, Arsen Osipov, Angela Mathison +5 more

Cancer-related cells and oncosomes in the liquid biopsy of pancreatic cancer patients undergoing surgery

npj Precision Oncology(2024)10.1038/s41698-024-00521-0

N/A

0DataRank · unranked

18 citations

Emmeline Lin, Nicholas N. Nissen, George Courcoubetis, Divya Suresh, Jeremy Mason +8 more

Neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma (PDAC) with germline DNA damage repair (DDR) mutations: A dual institution retrospective study.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.4164

N/A

0DataRank · unranked

1 citations

Marco Ventin, Giulia Cattaneo, Arya Shahrzad, Anser Abbas, Brent K. Larson +13 more

Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from a real-world evidence database

The Oncologist(2025)10.1093/oncolo/oyaf007

N/A

0DataRank · unranked

7 citations

Edik M. Blais, John Davelaar, Matthew Ebia, Angela Minasyan, Nima Nikravesh +13 more

Pan-cancer prediction of tumor immune activation and response to immune checkpoint blockade from tumor transcriptomics and histopathology

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.06.27.661875

N/A

0DataRank · unranked

0 citations

Sumeet Patiyal, Lipika R. Pal, Tiangen Chang, Sumona Biswas, Saugato Rahman Dhruba +36 more

Tumor Mutational Burden, Toxicity, and Response of Immune Checkpoint Inhibitors Targeting PD(L)1, CTLA-4, and Combination: A Meta-regression Analysis

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0458

N/A

0DataRank · unranked

109 citations

Su Jin Lim, Aleksandra Popović, Nilofer S. Azad, Daniel A. Laheru, Lei Zheng +4 more

Enhancing management of pancreatic cancer: impact of a same day multidisciplinary clinic on access to guideline-directed care

HPB(2025)10.1016/j.hpb.2025.07.012

N/A

0DataRank · unranked

0 citations

Anser Abbas, Abrahm Levi, John Davelaar, Elissa Rosenberg, Katelyn M. Atkins +18 more